Early disease and low baseline damage as predictors of response to belimumab in patients with systemic lupus erythematosus in a real‐life setting

M Gatto, F Saccon, M Zen, F Regola… - Arthritis & …, 2020 - Wiley Online Library
Objective To investigate predictors of response, remission, low disease activity, damage,
and drug discontinuation in patients with systemic lupus erythematosus (SLE) who were …
被引用次数：97 相关文章

Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting

M Gatto, F Saccon, M Zen, F Regola, M Fredi… - ARTHRITIS & …, 2020 - iris.univpm.it
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients
With Systemic Lupus Erythematosus in a Real-Life Setting IRIS IRIS Home Sfoglia …

Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting

M Gatto, F Saccon, M Zen, F Regola… - ARTHRITIS & …, 2020 - research.unipg.it
Objective: To investigate predictors of response, remission, low disease activity, damage,
and drug discontinuation in patients with systemic lupus erythematosus (SLE) who were …

Early disease and low baseline damage as predictors of response to belimumab in patients with Systemic Lupus Erythematosus in a real-life setting

M Gatto, F Saccon, M Zen, F Regola, M Fredi… - ARTHRITIS & …, 2020 - sfera.unife.it
Objective: To investigate predictors of response, remission, low disease activity, damage,
and drug discontinuation in patients with systemic lupus erythematosus (SLE) who were …

Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real‐Life Setting

M Gatto, F Saccon, M Zen, F Regola, M Fredi… - Arthritis & …, 2020 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Objective</jats: title>< jats: p> To investigate predictors of
response, remission, low disease activity, damage, and drug discontinuation in patients with …

Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting

M Gatto, F Saccon, M Zen, F Regola, M Fredi… - ARTHRITIS & …, 2020 - iris.unina.it
Objective: To investigate predictors of response, remission, low disease activity, damage,
and drug discontinuation in patients with systemic lupus erythematosus (SLE) who were …

[引用][C] Early disease and low baseline damage predict response to belimumab in patients with systemic lupus erythematosus

M Gatto, F Saccon, M Zen, F Regola… - ARTHRITIS & …, 2020 - research.unipd.it
To investigate predictors of response, remission, low disease activity (LDA), damage and
drug discontinuation in patients with systemic lupus erythematosus (SLE) treated with …

Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting

M Gatto, F Saccon, M Zen, F Regola, M Fredi… - ARTHRITIS & …, 2020 - iris.unitn.it
Objective. To investigate predictors of response, remission, low disease activity (LDA),
damage 3 and drug discontinuation in patients with systemic lupus erythematosus (SLE) …

Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting

M Gatto, F Saccon, M Zen, F Regola, M Fredi… - ARTHRITIS & …, 2020 - iris.unimore.it
Objective: To investigate predictors of response, remission, low disease activity, damage,
and drug discontinuation in patients with systemic lupus erythematosus (SLE) who were …

Early disease and low baseline damage as predictors of response to belimumab in patients with systemic lupus erythematosus in a real-life setting

M Gatto, F Saccon, M Zen, F Regola, M Fredi… - ARTHRITIS & …, 2020 - iris.unica.it
Objective: To investigate predictors of response, remission, low disease activity, damage,
and drug discontinuation in patients with systemic lupus erythematosus (SLE) who were …